Comparative analysis of secondary clinical evaluation data The analysis of secondary clinical data indicates that after the intervention with both drugs, significant time effects were observed in the assessments of HAMD ( P <0.001), HAMA ( P <0.001) and ESS ( P =0.031) scale scores, while group effects and interaction effects did not reach statistical significance ( P >0.05).
← all excerpts
Clinical efficacy of modified suanzaoren decoction compared to esazolam tablets in the treatment of chronic insomnia disorder.
1
0.0500
0.0500